Granules India (BOM:532482) Total Equity: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532482 Granules India Ltd BOM:532482
81 GF Score
Price ₹841.65
GF Value ₹637.97
Valuation Significantly Overvalued
! 7 Warning Signs
View Full Analysis

What is Granules India Total Equity?

Granules India BOM:532482 -0.48% 81 Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus rates BOM:532482 with a GF Score™ of 81/100 and a GF Value™ of ₹637.97 (Significantly Overvalued). The stock has 7 warning signs investors should review.

Granules India's total equity for the quarter that ended in Jun. 2026 was ₹0 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Granules India Total Equity Historical Data

* Premium members only.

The historical data trend for Granules India's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Granules India Total Equity Chart

Granules India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25,870.94 28,349.09 32,255.44 37,155.78 50,849.95

Granules India Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 39,827.77 0.00 50,849.95 0.00
BOM:532482
81GF Score
Granules India Ltd BOM:532482
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Granules India Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Granules India's Total Equity for the fiscal year that ended in Mar. 2026 is calculated as

Total Equity=Total Assets(Q: Mar. 2026 )-Total Liabilities(Q: Mar. 2026 )
=77199.5-26349.55
=50,850

Granules India's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of ₹0 Mil mean?
Granules India (BOM:532482) has a Total Equity of ₹0 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Granules India and its competitors.
Is Granules India's Total Equity too high?
Granules India's current Total Equity is ₹0 Mil. Overall, Granules India has a GF Score™ of 81/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Granules India's Total Equity compare to ZTS?
Granules India's Total Equity of ₹0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Drug Manufacturers company?
A good Total Equity depends on the Drug Manufacturers industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Granules India and its competitors. Granules India's current Total Equity is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Granules India stock overvalued right now?
Based on GuruFocus' analysis, Granules India (BOM:532482) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹637.97, compared to a current price of ₹841.65 — trading 31.9% above its estimated fair value. The current Total Equity is ₹0 Mil. Granules India's overall GF Score™ is 81/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Granules India (BOM:532482), the current Total Equity is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Granules India (BOM:532482) Overvalued in 2026?

Based on GuruFocus' analysis, Granules India stock appears to be overvalued. The current stock price of ₹841.65 is trading 31.9% above its estimated GF Value™ of ₹637.97. GuruFocus considers Granules India to be Significantly Overvalued.

Key valuation signals for BOM:532482:

  • Total Equity: ₹0 Mil
  • GF Value™: ₹637.97 vs. price of ₹841.65 (31.9% above fair value)
  • GF Score™: 81/100 with 7 warning signs

No single metric tells the full story. See the BOM:532482 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Granules India Business Description

Other Exchanges GRANULES:India
Address Botanical Garden Road, 15th Floor, Granules Tower, Kondapur, Hyderabad, TG, IND, 500084
Granules India Ltd is an India-based pharmaceutical company. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates, and finished dosages. It has one segment Pharmaceutical products including ingredients and intermediaries. Its primary geographic markets are North America, Latin America, Europe, India, and the Rest of the World. The company generates a majority of its revenue from its business outside India.
81GF Score

Get the complete analysis for BOM:532482

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹841.65
Price
₹637.97
GF Value